Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 9, 2022
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
Corinne Jenkins Maintained (BTAI) at Strong Sell with Decreased Target to $10 on, May 9th, 2022
Corinne Jenkins of Goldman Sachs, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Sell with Decreased Target from $17 to $10 on, May 9th, 2022.
Corinne has made no other calls on BTAI in the last 4 months.
There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Corinne
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $134 on, Thursday, April 14th, 2022
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $25 on, Wednesday, February 16th, 2022
